Tehran (IP) - Head of Actover pharmaceutical company Nahaleh Naraqi said that our youth in spite of US inhumane sanctions have produced Remdesivir which is approved by FDA only two weeks after other countries.

Iran Press/Iran News: In the ceremony which was held to inaugurate the production line of Remdesivir, Naraqi in an exclusive interview with Iran Press said that this product has been produced by Iranian technology with the same quality of foreign ones.

She went on to say that due to the imposed sanctions on Iran the production of this medicine was really hard in every step of preparing the raw materials, machinery, and laboratory equipment.

"Sanctions made us work ten times harder," she highlighted, noting that "Our youth and staff never give up in their way to reach to this national production."


Read More:

Iran's fight against coronavirus, affected by US sanctions: Minister

Iranian people fight COVID-19 under toughest sanctions: Labor Min.

Observing health protocols; only solution to contain coronavirus: Rouhani